COMPANY OVERVIEW
BERG Analytics takes artificial intelligence to a level never before seen in the world of analytics by providing real-time predictive and prescriptive solutions to optimize patient treatments and improve population health.
Our innovative machine learning platform, bAIcisTM, uses powerful artificial intelligence technology to deliver new insights and, with our skilled and experienced team, promote best practices to dramatically reduce adverse events and readmissions, while supporting value-based care initiatives.
BERG Analytics provides healthcare stakeholders with Actionable Patient IntelligenceTM to support the drive for better outcomes for healthcare companies and the patients they serve.
OUR PARENT COMPANY, BERG
BERG, LLC is a diversified biopharmaceutical company with Analytics, Pharma, Biosystems and Diagnostics business divisions. BERG’s research seeks to understand how alterations in metabolism relate to disease onset. The BERG research team has uncovered key insight into metabolic control factors and into the underlying elements in the Warburg Hypothesis. The company has a deep pipeline of preclinical assets in CNS and metabolic diseases that complement its late-stage clinical trial activity in cancer and prevention of chemo-toxicity. Armed with the use of the Interrogative Biology® discovery platform, BERG is poised to realize its pursuit of a healthier tomorrow.